The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea
- 14 August 2009
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 136 (2), 193-199
- https://doi.org/10.1016/j.ijcard.2008.04.045
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Impact of Atrial Fibrillation on the Diagnostic Performance of B-Type Natriuretic Peptide Concentration in Dyspneic Patients: An Analysis From the Breathing Not Properly Multinational StudyJournal of the American College of Cardiology, 2005
- The use of B‐type natriuretic peptide in the management of elderly patients with acute dyspnoeaJournal of Internal Medicine, 2005
- Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of CardiologyEuropean Heart Journal, 2005
- Newly Diagnosed Atrial FibrillationThe New England Journal of Medicine, 2004
- ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)Circulation, 2001
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001
- DyspneaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Causes of congestive heart failurePostgraduate Medicine, 1997
- The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up studyThe American Journal of Medicine, 1995
- Effects of prehospital medications on mortality and length of stay in congestive heart failureAnnals of Emergency Medicine, 1992